A citation-based method for searching scientific literature

Tomás Pulido, Igor Adzerikho, Richard N Channick, Marion Delcroix, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Pavel Jansa, Zhi-Cheng Jing, Franck-Olivier Le Brun, Sanjay Mehta, Camilla M Mittelholzer, Loïc Perchenet, B K S Sastry, Olivier Sitbon, Rogério Souza, Adam Torbicki, Xiaofeng Zeng, Lewis J Rubin, Gérald Simonneau. N Engl J Med 2013
Times Cited: 823







List of co-cited articles
1411 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Selexipag for the Treatment of Pulmonary Arterial Hypertension.
Olivier Sitbon, Richard Channick, Kelly M Chin, Aline Frey, Sean Gaine, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Irene M Lang, Ralph Preiss,[...]. N Engl J Med 2015
515
52

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Nazzareno Galiè, Joan A Barberà, Adaani E Frost, Hossein-Ardeschir Ghofrani, Marius M Hoeper, Vallerie V McLaughlin, Andrew J Peacock, Gérald Simonneau, Jean-Luc Vachiery, Ekkehard Grünig,[...]. N Engl J Med 2015
642
50


Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
44

Riociguat for the treatment of pulmonary arterial hypertension.
Hossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, Ekkehard Grünig, Marc Humbert, Zhi-Cheng Jing, Anne M Keogh, David Langleben, Michael Ochan Kilama, Arno Fritsch,[...]. N Engl J Med 2013
804
41

Bosentan therapy for pulmonary arterial hypertension.
Lewis J Rubin, David B Badesch, Robyn J Barst, Nazzareno Galie, Carol M Black, Anne Keogh, Tomas Pulido, Adaani Frost, Sebastien Roux, Isabelle Leconte,[...]. N Engl J Med 2002
34

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
Nazzareno Galiè, Horst Olschewski, Ronald J Oudiz, Fernando Torres, Adaani Frost, Hossein A Ghofrani, David B Badesch, Michael D McGoon, Vallerie V McLaughlin, Ellen B Roecker,[...]. Circulation 2008
692
33

Sildenafil citrate therapy for pulmonary arterial hypertension.
Nazzareno Galiè, Hossein A Ghofrani, Adam Torbicki, Robyn J Barst, Lewis J Rubin, David Badesch, Thomas Fleming, Tamiza Parpia, Gary Burgess, Angelo Branzi,[...]. N Engl J Med 2005
28

Tadalafil therapy for pulmonary arterial hypertension.
Nazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, Ronald J Oudiz, Gerald Simonneau, Zeenat Safdar, Shelley Shapiro, R James White, Melanie Chan, Anthony Beardsworth,[...]. Circulation 2009
711
28


Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Athénaïs Boucly, Jason Weatherald, Laurent Savale, Xavier Jaïs, Vincent Cottin, Grégoire Prevot, François Picard, Pascal de Groote, Mitja Jevnikar, Emmanuel Bergot,[...]. Eur Respir J 2017
365
22

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Marius M Hoeper, Tilmann Kramer, Zixuan Pan, Christina A Eichstaedt, Jens Spiesshoefer, Nicola Benjamin, Karen M Olsson, Katrin Meyer, Carmine Dario Vizza, Anton Vonk-Noordegraaf,[...]. Eur Respir J 2017
347
21

Risk stratification and medical therapy of pulmonary arterial hypertension.
Nazzareno Galiè, Richard N Channick, Robert P Frantz, Ekkehard Grünig, Zhi Cheng Jing, Olga Moiseeva, Ioana R Preston, Tomas Pulido, Zeenat Safdar, Yuichi Tamura,[...]. Eur Respir J 2019
399
21

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
R J Barst, L J Rubin, W A Long, M D McGoon, S Rich, D B Badesch, B M Groves, V F Tapson, R C Bourge, B H Brundage,[...]. N Engl J Med 1996
20

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
Vallerie V McLaughlin, Raymond L Benza, Lewis J Rubin, Richard N Channick, Robert Voswinckel, Victor F Tapson, Ivan M Robbins, Horst Olschewski, Melvyn Rubenfire, Werner Seeger. J Am Coll Cardiol 2010
371
19

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
R James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepulveda, Kuo Yang Wang, Ekkehard Grünig, Shirish Hiremath, Zaixin Yu, Zhang Gangcheng,[...]. Am J Respir Crit Care Med 2020
47
40

Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
Zhi-Cheng Jing, Keyur Parikh, Tomas Pulido, Carlos Jerjes-Sanchez, R James White, Roblee Allen, Adam Torbicki, Kai-Feng Xu, David Yehle, Kevin Laliberte,[...]. Circulation 2013
224
18

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
Gerald Simonneau, Robyn J Barst, Nazzareno Galie, Robert Naeije, Stuart Rich, Robert C Bourge, Anne Keogh, Ronald Oudiz, Adaani Frost, Shelmer D Blackburn,[...]. Am J Respir Crit Care Med 2002
965
18

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
David Kylhammar, Barbro Kjellström, Clara Hjalmarsson, Kjell Jansson, Magnus Nisell, Stefan Söderberg, Gerhard Wikström, Göran Rådegran. Eur Heart J 2018
271
17

Inhaled iloprost for severe pulmonary hypertension.
Horst Olschewski, Gerald Simonneau, Nazzareno Galiè, Timothy Higenbottam, Robert Naeije, Lewis J Rubin, Sylvia Nikkho, Rudolf Speich, Marius M Hoeper, Jürgen Behr,[...]. N Engl J Med 2002
17

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
Raymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, Harrison W Farber, Aimee J Foreman, Adaani E Frost, Michael D McGoon, David J Pasta, Mona Selej, Charles D Burger,[...]. Chest 2019
248
16

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial.
Victor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman, David G Kiely, Eugene Kotlyar, C Shane McSwain, Kevin Laliberte, Carl Arneson,[...]. Chest 2013
204
16

Pulmonary arterial hypertension in France: results from a national registry.
Marc Humbert, Olivier Sitbon, Ari Chaouat, Michèle Bertocchi, Gilbert Habib, Virginie Gressin, Azzedine Yaici, Emmanuel Weitzenblum, Jean-François Cordier, François Chabot,[...]. Am J Respir Crit Care Med 2006
16

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Victor F Tapson, Fernando Torres, Fiona Kermeen, Anne M Keogh, Roblee P Allen, Robert P Frantz, David B Badesch, Adaani E Frost, Shelley M Shapiro, Kevin Laliberte,[...]. Chest 2012
231
15

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
R N Channick, G Simonneau, O Sitbon, I M Robbins, A Frost, V F Tapson, D B Badesch, S Roux, M Rainisio, F Bodin,[...]. Lancet 2001
15

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Nazzareno Galiè, Maurice Beghetti, Michael A Gatzoulis, John Granton, Rolf M F Berger, Andrea Lauer, Eleonora Chiossi, Michael Landzberg. Circulation 2006
564
14

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Olivier Sitbon, Marc Humbert, Xavier Jaïs, Vincent Ioos, Abdul M Hamid, Steeve Provencher, Gilles Garcia, Florence Parent, Philippe Hervé, Gérald Simonneau. Circulation 2005
701
14

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
N Galiè, Lj Rubin, Mm Hoeper, P Jansa, H Al-Hiti, Gmb Meyer, E Chiossi, A Kusic-Pajic, G Simonneau. Lancet 2008
640
14

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.
Vallerie McLaughlin, Richard N Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, Victor F Tapson, Jonathan Tolson, Hikmet Al Hiti,[...]. Eur Respir J 2015
144
13

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
G E D'Alonzo, R J Barst, S M Ayres, E H Bergofsky, B H Brundage, K M Detre, A P Fishman, R M Goldring, B M Groves, J T Kernis. Ann Intern Med 1991
13

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.
Sean Gaine, Kelly Chin, Gerry Coghlan, Richard Channick, Lilla Di Scala, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Irene M Lang, Vallerie McLaughlin, Ralph Preiss,[...]. Eur Respir J 2017
54
22

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Olivier Sitbon, Xavier Jaïs, Laurent Savale, Vincent Cottin, Emmanuel Bergot, Elise Artaud Macari, Hélène Bouvaist, Claire Dauphin, François Picard, Sophie Bulifon,[...]. Eur Respir J 2014
222
12

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.
Vallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, Victor F Tapson, Srinivas Murali, Richard N Channick, David B Badesch, Robyn J Barst, Henry H Hsu, Lewis J Rubin. Am J Respir Crit Care Med 2006
424
12

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Gérald Simonneau, Lewis J Rubin, Nazzareno Galiè, Robyn J Barst, Thomas R Fleming, Adaani E Frost, Peter J Engel, Mordechai R Kramer, Gary Burgess, Lorraine Collings,[...]. Ann Intern Med 2008
449
12

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, Friedrich Grimminger, Jian-Guo He, Gabriela Riemekasten, Carmine Dario Vizza, Annette Boeckenhoff, Christian Meier, Janethe de Oliveira Pena,[...]. Ann Rheum Dis 2017
69
17

Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis.
Annie Christine Lajoie, Gabriel Lauzière, Jean-Christophe Lega, Yves Lacasse, Sylvie Martin, Serge Simard, Sebastien Bonnet, Steeve Provencher. Lancet Respir Med 2016
142
11

Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Michael A Gatzoulis, Michael Landzberg, Maurice Beghetti, Rolf M Berger, Michela Efficace, Sophie Gesang, Jian'guo He, Kelly Papadakis, Tomás Pulido, Nazzareno Galiè. Circulation 2019
55
20

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Hossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, Marius M Hoeper, Pavel Jansa, Nick H Kim, Eckhard Mayer, Gerald Simonneau, Martin R Wilkins, Arno Fritsch,[...]. N Engl J Med 2013
792
11

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.
D B Badesch, V F Tapson, M D McGoon, B H Brundage, L J Rubin, F M Wigley, S Rich, R J Barst, P S Barrett, K M Kral,[...]. Ann Intern Med 2000
763
11

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
M Humbert, R J Barst, I M Robbins, R N Channick, N Galiè, A Boonstra, L J Rubin, E M Horn, A Manes, G Simonneau. Eur Respir J 2004
436
11

Beraprost therapy for pulmonary arterial hypertension.
Robyn J Barst, Michael McGoon, Vallerie McLaughlin, Victor Tapson, Stuart Rich, Lewis Rubin, Karlman Wasserman, Ronald Oudiz, Shelley Shapiro, Ivan M Robbins,[...]. J Am Coll Cardiol 2003
426
11

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Raymond L Benza, Dave P Miller, Robyn J Barst, David B Badesch, Adaani E Frost, Michael D McGoon. Chest 2012
654
11

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, Robert P Frantz, Aimee J Foreman, Christopher S Coffey, Adaani Frost, Robyn J Barst, David B Badesch, C Gregory Elliott,[...]. Circulation 2010
11

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.
Kelly M Chin, Olivier Sitbon, Martin Doelberg, Jeremy Feldman, J Simon R Gibbs, Ekkehard Grünig, Marius M Hoeper, Nicolas Martin, Stephen C Mathai, Vallerie V McLaughlin,[...]. J Am Coll Cardiol 2021
28
39

Clinical trial design and new therapies for pulmonary arterial hypertension.
Olivier Sitbon, Mardi Gomberg-Maitland, John Granton, Michael I Lewis, Stephen C Mathai, Maurizio Rainisio, Norman L Stockbridge, Martin R Wilkins, Roham T Zamanian, Lewis J Rubin. Eur Respir J 2019
103
10

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
J Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müller-Ladner, Janet E Pope, Madelon C Vonk, Martin Doelberg,[...]. Ann Rheum Dis 2014
434
10

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
M M Hoeper, H Leuchte, M Halank, H Wilkens, F J Meyer, H J Seyfarth, R Wensel, F Ripken, H Bremer, S Kluge,[...]. Eur Respir J 2006
206
10


Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.
Marc Humbert, Olivier Sitbon, Ari Chaouat, Michèle Bertocchi, Gilbert Habib, Virginie Gressin, Azzedine Yaïci, Emmanuel Weitzenblum, Jean-François Cordier, François Chabot,[...]. Circulation 2010
10

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension.
Gérald Simonneau, Adam Torbicki, Marius M Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace,[...]. Eur Respir J 2012
209
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.